Mar 192017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, GA – MiMedx Group, Inc. (NASDAQ:MDXG), the leading regenerative medicine and biopharmaceutical company utilizing human placental tissue allografts and patent-protected processes to develop and market advanced products and therapies for multiple sectors of healthcare, announced today its Board of Directors has appointed Luis A.

=> Read more

MiMedx adds Luis Aguilar to its Board as Independent Director

From:: MiMedx adds Luis Aguilar to its Board as Independent Director

Sorry, the comment form is closed at this time.

%d bloggers like this: